Simplify Asset Management Inc. grew its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 61.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,972 shares of the company’s stock after buying an additional 2,277 shares during the quarter. Simplify Asset Management Inc.’s holdings in Henry Schein were worth $435,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of HSIC. SG Americas Securities LLC grew its stake in shares of Henry Schein by 66.4% during the first quarter. SG Americas Securities LLC now owns 16,202 shares of the company’s stock valued at $1,224,000 after buying an additional 6,468 shares during the last quarter. State Board of Administration of Florida Retirement System raised its stake in Henry Schein by 7.0% during the first quarter. State Board of Administration of Florida Retirement System now owns 185,054 shares of the company’s stock valued at $15,089,000 after buying an additional 12,087 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Henry Schein by 32.6% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 161,517 shares of the company’s stock valued at $12,198,000 after buying an additional 39,739 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after acquiring an additional 260,537 shares during the last quarter. Finally, TIAA Trust National Association increased its holdings in shares of Henry Schein by 4.9% during the first quarter. TIAA Trust National Association now owns 5,440 shares of the company’s stock valued at $411,000 after acquiring an additional 252 shares in the last quarter. 96.62% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research analysts have recently issued reports on HSIC shares. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Robert W. Baird dropped their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Evercore ISI increased their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $78.89.
Insider Transactions at Henry Schein
In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.14% of the company’s stock.
Henry Schein Price Performance
Shares of HSIC stock traded up $0.16 during trading hours on Friday, hitting $66.70. The stock had a trading volume of 263,604 shares, compared to its average volume of 1,347,820. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The stock’s 50-day moving average price is $70.30 and its two-hundred day moving average price is $69.59. The stock has a market capitalization of $8.32 billion, a price-to-earnings ratio of 27.38, a PEG ratio of 1.94 and a beta of 0.87.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period last year, the firm posted $1.32 earnings per share. Equities analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Top-Performing Non-Leveraged ETFs This Year
- The How And Why of Investing in Oil Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Do ETFs Pay Dividends? What You Need to Know
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.